Abstract
Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID-19 Patients: A Perspective from an Israeli Cross-Sector Collaboration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have